Rocket Lab's $3B ATM Casts Shadow Over Record-Breaking Week

Rocket Lab stock hit $139.76 after a $90M Space Force contract and Electron launch, but a $3B equity program and insider selling temper optimism. Valuation stands at 78x EV/sales.

Rocket Lab investors had plenty to cheer about last week — a new all-time high of $139.76, a pair of major contract wins, and another successful Electron launch — but a three-billion-dollar share sale filed just ahead of the good news has introduced a note of caution. The stock closed Friday at $135.76, up 8.22% on the day and more than five times its level 12 months ago. Yet that gain came on the heels of a 6.6% pre-market dip triggered by the company's at-the-market equity program registered on May 20.

The program, administered through Goldman Sachs, BofA Securities and Morgan Stanley, allows Rocket Lab to sell up to $3 billion in new shares at its discretion. Proceeds are earmarked for growth initiatives, potential acquisitions and general corporate purposes — with the pending purchase of Motiv Space Systems likely absorbing a significant chunk. That deal, expected to close in the second quarter of 2026, will bring in-space robotics and precision mechanism technology that has already flown on NASA's Perseverance rover and the CADRE lunar vehicle. Motiv will be rebranded as Rocket Lab Robotics upon completion.

The rally itself was fueled by two announcements within 24 hours. On May 21, the U.S. Space Force's Space Systems Command awarded Rocket Lab a $90 million contract to build, integrate and operate two geostationary satellites carrying classified government payloads. The next day, the "Viva La StriX" mission lifted off from Launch Complex 1 in New Zealand, placing the latest Synspective satellite into a 572-kilometer orbit. That flight marked the ninth dedicated launch for the Japanese Earth-observation company, with 18 more already booked — all slated to fill out the synthetic aperture radar constellation by 2030.

Rocket Lab's Electron rocket has now flown 88 missions in total. The company also highlighted a custom payload fairing designed specifically for the StriX satellite, contributing to a 100% success rate on that customer's flights. For the broader business, the first quarter of 2026 delivered record revenue of $200.3 million, up 63.5% year-over-year, and a GAAP gross margin of 38.2%. The backlog swelled to $2.2 billion, a more than 20% sequential increase, supported by 31 new Electron and HASTE contracts plus five firm orders for the upcoming Neutron rocket.

That growth has not gone unnoticed by analysts, though the stock's rapid ascent has left many price targets in the dust. CFRA maintains a $140 12-month target, while Deutsche Bank, TD Cowen, Clear Street, Craig-Hallum, Citizens and New Street Research have all raised their estimates and kept buy or outperform ratings. Still, the valuation gives even the bulls pause: Rocket Lab trades at roughly 78 times its projected 2026 enterprise-value-to-sales ratio, far above the mid-to-high single-digit multiples typical for the sector.

Insider selling adds another layer of caution. Cathie Wood's ARKX and ARKQ ETFs unloaded 365,680 Rocket Lab shares in May, while board member Alexander R. Slusky sold 100,000 shares on May 12 for about $11.8 million, though he retains 493,524 shares.

Sector dynamics provided a tailwind as well. Confirmation that SpaceX is exploring an initial public offering lifted space-related stocks broadly, and Rocket Lab was among the strongest gainers. The company's own pipeline remains packed: the next Electron mission, "The Grain Goddess Provides," will carry a satellite for Japanese customer iQPS as early as June 2026 from the New Zealand site. Additional launches for the U.S. Space Force and NASA are on the calendar, and the first flight of the larger Neutron rocket is still targeted for 2026, with five dedicated missions already under contract.

For now, Rocket Lab expects second-quarter revenue of $225 to $240 million and a non-GAAP gross margin of 38% to 40%. The next earnings report won't arrive until August, leaving the stock to trade on macro conditions, launch announcements and — perhaps most critically — the market's evolving view of that three-billion-dollar overhang.